How Tolerogenic Dendritic Cells Induce Regulatory T Cells

Advances in Immunology

Volumn 108, Issue C, 2010, Pages 111-165

  Maldonado, Roberto A ^a   von Andrian, Ulrich H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PREDNISOLONE; RAPAMYCIN; RESVERATROL;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BOOK; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; DRUG MECHANISM; EFFECTOR CELL; GENE INDUCTION; GENETIC MANIPULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LYMPHOID ORGAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TISSUE INJURY;

EID: 78149277909     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-380995-7.00004-5     Document Type: Chapter

References (363)

1. Adorini L., Penna G. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb. Exp. Pharmacol. 2009, 251-273.
2. Aggarwal B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
3. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 2:725-731.
4. Akbari O., Freeman G., Meyer E., Greenfield E., Chang T., Sharpe A., Berry G., DeKruyff R., Umetsu D. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 2002, 8:1024-1032.
5. Akdis C.A., Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001, 103:131-136.
6. Akdis C.A., Joss A., Akdis M., Faith A., Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J. 2000, 14:1666-1668.
7. Akdis C.A., Joss A., Akdis M., Blaser K. Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens. Int. Arch. Allergy Immunol. 2001, 124:180-182.
8. Allam J.-P., Peng W.-M., Appel T., Wenghoefer M., Niederhagen B., Bieber T., Bergé S., Novak N. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J. Allergy Clin. Immunol. 2008, 121:368-374.e361.
9. Alvarez D., Vollmann E.H., von Andrian U.H. Mechanisms and consequences of dendritic cell migration. Immunity 2008, 29:325-342.
10. Anderson A.E., Sayers B.L., Haniffa M.A., Swan D.J., Diboll J., Wang X.-N., Isaacs J.D., Hilkens C.M.U. Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells. J. Leukoc. Biol. 2008, 84:124-133.
11. Anderson A.E., Swan D.J., Sayers B.L., Harry R.A., Patterson A.M., von Delwig A., Robinson J.H., Isaacs J.D., Hilkens C.M.U. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J. Leukoc. Biol. 2009, 85:243-250.
12. Andersson J., Tran D., Pesu M., Davidson T., Ramsey H., O'Shea J., Shevach E. CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-{beta}-dependent manner. J. Exp. Med. 2008, 205:1975-1981.
13. Apostolou I., von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 2004, 199:1401-1408.
14. Aschenbrenner K., D'Cruz L.M., Vollmann E.H., Hinterberger M., Emmerich J., Swee L.K., Rolink A., Klein L. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat. Immunol. 2007, 8:351-358.
15. Atibalentja D.F., Byersdorfer C.A., Unanue E.R. Thymus-blood protein interactions are highly effective in negative selection and regulatory T cell induction. J. Immunol. 2009, 183:7909-7918.
16. Augustine J.J., Bodziak K.A., Hricik D.E. Use of sirolimus in solid organ transplantation. Drugs 2007, 67:369-391.
17. Bakocević N., Worbs T., Davalos-Misslitz A., Förster R. T cell-dendritic cell interaction dynamics during the induction of respiratory tolerance and immunity. J. Immunol. 2010, 184:1317-1327.
18. Bamboat Z.M., Stableford J.A., Plitas G., Burt B.M., Nguyen H.M., Welles A.P., Gonen M., Young J.W., DeMatteo R.P. Human liver dendritic cells promote T cell hyporesponsiveness. J. Immunol. 2009, 182:1901-1911.
19. Bamboat Z.M., Ocuin L.M., Balachandran V.P., Obaid H., Plitas G., DeMatteo R.P. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J. Clin. Invest. 2010, 120:559-569.
20. Banchereau J., Briere F., Caux C., Davoust J. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
21. Bar-On L., Jung S. Defining dendritic cells by conditional and constitutive cell ablation. Immunol. Rev. 2010, 234:76-89.
22. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science 2003, 300:1524-1525.
23. Battaglia M., Stabilini A., Roncarolo M. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005, 105:4743-4748.
24. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., Roncarolo M. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 2006, 177:8338-8347.
25. Belkaid Y. Regulatory T cells and infection: A dangerous necessity. Nat. Rev. Immunol. 2007, 7:875-888.
26. Belkaid Y., Oldenhove G. Tuning microenvironments: Induction of regulatory T cells by dendritic cells. Immunity 2008, 29:362-371.
27. Belladonna M.L., Volpi C., Bianchi R., Vacca C., Orabona C., Pallotta M.T., Boon L., Gizzi S., Fioretti M.C., Grohmann U., Puccetti P. Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. J. Immunol. (Baltimore, MD: 1950) 2008, 181:5194-5198.
28. Belladonna M.L., Orabona C., Grohmann U., Puccetti P. TGF-beta and kynurenines as the key to infectious tolerance. Trends Mol. Med. 2009, 15:41-49.
29. Benkhoucha M., Santiago-Raber M.-L., Schneiter G., Chofflon M., Funakoshi H., Nakamura T., Lalive P.H. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2010, 107:6424-6429.
30. Ben-Shoshan J., Maysel-Auslender S., Mor A., Keren G., George J. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis viahypoxia-inducible factor-1α. Eur. J. Immunol. 2008, 38:2412-2418.
31. Bensinger S., Bandeira A., Jordan M., Caton A., Laufer T. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med. 2001, 194:427-438.
32. Benson M., Pino-Lagos K., Rosemblatt M., Noelle R. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 2007, 204:1765-1774.
33. Bernabeu C., Lopez-Novoa J.M., Quintanilla M. The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim. Biophys. Acta 2009, 1792:954-973.
34. Besin G., Gaudreau S., Ménard M., Guindi C., Dupuis G., Amrani A. Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes. Diabetes 2008, 57:2107-2117.
35. Bierie B., Moses H.L. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 2010, 21:49-59.
36. Bilenki L., Gao X., Wang S., Yang J., Fan Y., Han X., Qiu H., Yang X. Dendritic cells from mycobacteria-infected mice inhibits established allergic airway inflammatory responses to ragweed via IL-10- and IL-12-secreting mechanisms. J. Immunol. 2010, 184:7288-7296.
37. Bilsborough J., George T.C., Norment A., Viney J.L. Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 2003, 108:481-492.
38. Birnberg T., Bar-On L., Sapoznikov A., Caton M.L., Cervantes-Barragán L., Makia D., Krauthgamer R., Brenner O., Ludewig B., Brockschnieder D., Riethmacher D., Reizis B., et al. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 2008, 29:986-997.
39. Bluestone J., Abbas A. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 2003, 3:253-257.
40. Bonasio R., Scimone M.L., Schaerli P., Grabie N., Lichtman A.H., von Andrian U.H. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 2006, 7:1092-1100.
41. Bonifazi P., Zelante T., D'Angelo C., De Luca A., Moretti S., Bozza S., Perruccio K., Iannitti R.G., Giovannini G., Volpi C., Fallarino F., Puccetti P., et al. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol. 2009, 2:362-374.
42. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
43. Bruder D., Westendorf A.M., Hansen W., Prettin S., Gruber A.D., Qian Y., von Boehmer H., Mahnke K., Buer J. On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 2005, 54:3395-3401.
44. Buckland M., Lombardi G. Aspirin and the induction of tolerance by dendritic cells. Handb. Exp. Pharmacol. 2009, 197-213.
45. Buckland M., Jago C., Fazekesova H., George A., Lechler R., Lombardi G. Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells. Int. Immunopharmacol. 2006, 6:1895-1901.
46. Buckland M., Jago C.B., Fazekasova H., Scott K., Tan P.H., George A.J.T., Lechler R., Lombardi G. Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am. J. Transplant. 2006, 6:2046-2059.
47. Cao O., Dobrzynski E., Wang L., Nayak S., Mingle B., Terhorst C., Herzog R.W. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood 2007, 110:1132-1140.
48. Cao W., Manicassamy S., Tang H., Kasturi S.P., Pirani A., Murthy N., Pulendran B. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat. Immunol. 2008, 9:1157-1164.
49. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., Lederman S., Colonna M., Cortesini R., Dalla-Favera R., Suciu-Foca N. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 2002, 3:237-243.
50. Chang W.L.W., Baumgarth N., Yu D., Barry P.A. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol. 2004, 78:8720-8731.
51. Chang W.L.W., Barry P.A., Szubin R., Wang D., Baumgarth N. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 2009, 390:330-337.
52. Chen W., Konkel J.E. TGF-beta and 'adaptive' Foxp3(+) regulatory T cells. J. Mol. Cell Biol. 2010, 2:30-36.
53. Chen W., Jin W., Hardegen N., Lei K., Li L., Marinos N., McGrady G., Wahl S. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
54. Chen W., Liang X., Peterson A.J., Munn D.H., Blazar B.R. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. (Baltimore, MD: 1950) 2008, 181:5396-5404.
55. Chieppa M., Rescigno M., Huang A.Y.C., Germain R.N. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 2006, 203:2841-2852.
56. Chora A.A., Fontoura P., Cunha A., Pais T.F., Cardoso S., Ho P.P., Lee L.Y., Sobel R.A., Steinman L., Soares M.P. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 2007, 117:438-447.
57. Chorny A., Gonzalez-Rey E., Fernandez-Martin A., Pozo D., Ganea D., Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc. Natl. Acad. Sci. USA 2005, 102:13562-13567.
58. Chorny A., Gonzalez-Rey E., Fernandez-Martin A., Ganea D., Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response. Blood 2006, 107:3787-3794.
59. Cobbold S.P., Adams E., Farquhar C.A., Nolan K.F., Howie D., Lui K.O., Fairchild P.J., Mellor A.L., Ron D., Waldmann H. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. USA 2009, 106:12055-12060.
60. Cong Y., Wang L., Konrad A., Schoeb T., Elson C. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells. Eur. J. Immunol. 2009, 39:3134-3146.
61. Connolly M.K., Bedrosian A.S., Mallen-St Clair J., Mitchell A.P., Ibrahim J., Stroud A., Pachter H.L., Bar-Sagi D., Frey A.B., Miller G. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Invest. 2009, 119:3213-3225.
62. Cools N., Van Tendeloo V.F.I., Smits E.L.J.M., Lenjou M., Nijs G., Van Bockstaele D.R., Berneman Z.N., Ponsaerts P. Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells. J. Cell. Mol. Med. 2008, 12:690-700.
63. Coombes J.L., Powrie F. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 2008, 8:435-446.
64. Coombes J., Siddiqui K., Arancibia-Carcamo C., Hall J., Sun C., Belkaid Y., Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-{beta} and retinoic acid dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
65. Cooper J.E., Wiseman A.C. Novel immunosuppressive agents in kidney transplantation. Clin. Nephrol. 2010, 73:333-343.
66. Coquerelle C., Moser M. DC subsets in positive and negative regulation of immunity. Immunol. Rev. 2010, 234:317-334.
67. Corrigall V.M., Vittecoq O., Panayi G.S. Binding immunoglobulin protein-treated peripheral blood monocyte-derived dendritic cells are refractory to maturation and induce regulatory T-cell development. Immunology 2009, 128:218-226.
68. Crispe I.N., Giannandrea M., Klein I., John B., Sampson B., Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol. Rev. 2006, 213:101-118.
69. Croker B.A., Krebs D.L., Zhang J.-G., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Förster I., Clausen B.E., Nicola N.A., Metcalf D., et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 2003, 4:540-545.
70. Cronin S.J.F., Penninger J.M. From T-cell activation signals to signaling control of anti-cancer immunity. Immunol. Rev. 2007, 220:151-168.
71. Curotto de Lafaille M.A., Kutchukhidze N., Shen S., Ding Y., Yee H., Lafaille J.J. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008, 29:114-126.
72. Curti A., Trabanelli S., Salvestrini V., Baccarani M., Lemoli R.M. The role of indoleamine 2, 3-dioxygenase in the induction of immune tolerance: Focus on hematology. Blood 2009, 113:2394-2401.
73. D'Ambrosio A., Colucci M., Pugliese O., Quintieri F., Boirivant M. Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation. J. Leukoc. Biol. 2008, 84:661-668.
74. Darrasse-Jeze G., Deroubaix S., Mouquet H., Victora G.D., Eisenreich T., Yao K.-H., Masilamani R.F., Dustin M.L., Rudensky A., Liu K., Nussenzweig M.C. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 2009, 206:1853-1862.
75. de Heer H.J., Hammad H., Soullié T., Hijdra D., Vos N., Willart M.A.M., Hoogsteden H.C., Lambrecht B.N. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 2004, 200:89-98.
76. Delgado M., Gonzalez-Rey E., Ganea D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J. Immunol. (Baltimore, MD: 1950) 2005, 175:7311-7324.
77. Delgoffe G.M., Powell J.D. mTOR: Taking cues from the immune microenvironment. Immunology 2009, 127:459-465.
78. Depaolo R.W., Tang F., Kim I., Han M., Levin N., Ciletti N., Lin A., Anderson D., Schneewind O., Jabri B. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008, 4:350-361.
79. Dhodapkar M., Steinman R. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002, 100:174-177.
80. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001, 193:233-238.
81. Dignass A.U., Podolsky D.K. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor beta. Gastroenterology 1993, 105:1323-1332.
82. Dumitriu I.E., Dunbar D.R., Howie S.E., Sethi T., Gregory C.D. Human dendritic cells produce TGF-1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 2009, 182:2795-2807.
83. Elgueta R., Benson M.J., de Vries V.C., Wasiuk A., Guo Y., Noelle R.J. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 2009, 229:152-172.
84. Esposito M., Ruffini F., Bellone M., Gagliani N., Battaglia M., Martino G., Furlan R. Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation. J. Neuroimmunol. 2010, 1-12.
85. Fainaru O., Shay T., Hantisteanu S., Goldenberg D., Domany E., Groner Y. TGF[beta]-dependent gene expression profile during maturation of dendritic cells. Genes Immun. 2007, 8:239-244.
86. Fainaru O., Adini A., Benny O., Adini I., Short S., Bazinet L., Nakai K., Pravda E., Hornstein M.D., D'Amato R.J., Folkman J. Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. FASEB J. 2008, 22:522-529.
87. Fainaru O., Almog N., Yung C.W., Nakai K., Montoya-Zavala M., Abdollahi A., D'Amato R., Ingber D.E. Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells. FASEB J. 2010, 24:1411-1418.
88. Falcón C., Carranza F., Martínez F.F., Knubel C.P., Masih D.T., Motrán C.C., Cervi L. Excretory-secretory products (ESP) from Fasciola hepatica induce tolerogenic properties in myeloid dendritic cells. Vet. Immunol. Immunopathol. 2010, 137:36-46.
89. Farquhar C.A., Paterson A.M., Cobbold S.P., Rueda H.G., Fairchild P.J., Yates S.F., Adams E., Saunders N.J., Waldmann H., Nolan K.F. Tolerogenicity is not an absolute property of a dendritic cell. Eur. J. Immunol. 2010, 40:1728-1737.
90. Feuerer M., Shen Y., Littman D.R., Benoist C., Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009, 31:654-664.
91. Feuerer M., Hill J.A., Kretschmer K., Von Boehmer H., Mathis D., Benoist C. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. USA 2010, 107:5919-5924.
92. Fiore F., Nuschak B., Peola S., Mariani S., Muraro M., Foglietta M., Coscia M., Bruno B., Boccadoro M., Massaia M. Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells. Eur. J. Immunol. 2005, 35:1155-1163.
93. Fishman P.H., Orlandi P.A. Cholera toxin internalization and intoxication. J. Cell Sci. 2003, 116:431-432. (author reply 432-433).
94. Fisson S., Darrasse-Jeze G., Litvinova E., Septier F., Klatzmann D., Liblau R., Salomon B. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med. 2003, 198:737-746.
95. Fleming S.B., Haig D.M., Nettleton P., Reid H.W., McCaughan C.A., Wise L.M., Mercer A. Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus. Virus Genes 2000, 21:85-95.
96. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
97. Förster R., Davalos-Misslitz A., Rot A. CCR7 and its ligands: Balancing immunity and tolerance. Nat. Rev. Immunol. 2008, 8:362-371.
98. Franchi L., Muñoz-Planillo R., Reimer T., Eigenbrod T., Núñez G. Inflammasomes as microbial sensors. Eur. J. Immunol. 2010, 40:611-615.
99. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., Sharpe A.H. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 2009, 206:3015-3029.
100. Friedman S.L., Rockey D.C., McGuire R.F., Maher J.J., Boyles J.K., Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: Morphological and functional characteristics in primary culture. Hepatology 1992, 15:234-243.
101. Fu B.-M., He X.-S., Yu S., Hu A.-B., Ma Y., Wu L.-W., Tam N.-L., Huang J.-F. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells. Exp. Clin. Transplant. 2009, 7:149-156.
102. Fu B.-M., He X.-S., Yu S., Hu A.-B., Zhang J., Ma Y., Tam N.-L., Huang J.-F. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice. Cell. Immunol. 2010, 261:69-76.
103. Fujita S., Sato Y., Sato K., Eizumi K., Fukaya T., Kubo M., Yamashita N., Sato K. Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+ regulatory T cells. Blood 2007, 110:3793-3803.
104. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 2004, 4:941-952.
105. Ganesh B.B., Cheatem D.M., Sheng J.R., Vasu C., Prabhakar B.S. GM-CSF-induced CD11c+CD8a-dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int. Immunol. 2009, 21:269-282.
106. Ge W., Jiang J., Baroja M.L., Arp J., Zassoko R., Liu W., Bartholomew A., Garcia B., Wang H. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am. J. Transplant. 2009, 9:1760-1772.
107. Ghiringhelli F., Puig P.E., Roux S., Parcellier A., Schmitt E., Solary E., Kroemer G., Martin F., Chauffert B., Zitvogel L. Tumor cells convert immature myeloid dendritic cells into TGF-{beta}-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med. 2005, 202:919-929.
108. Goddard S., Youster J., Morgan E., Adams D.H. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am. J. Pathol. 2004, 164:511-519.
109. Göke M., Kanai M., Podolsky D.K. Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am. J. Physiol. 1998, 274:G809-G818.
110. Gomez-Escobar N., Gregory W.F., Maizels R.M. Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi. Infect. Immun. 2000, 68:6402-6410.
111. Gonzalez-Rey E., Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology 2006, 131:1799-1811.
112. Gonzalez-Rey E., Chorny A., Fernandez-Martin A., Ganea D., Delgado M. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 2006, 107:3632-3638.
113. Gorczynski R.M. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection. Transplantation 2006, 81:1027-1034.
114. Gorczynski R.M., Chen Z., Kai Y., Wong S., Lee L. Induction of tolerance-inducing antigen-presenting cells in bone marrow cultures in vitro using monoclonal antibodies to CD200R. Transplantation 2004, 77:1138-1144.
115. Gorczynski R.M., Lee L., Boudakov I. Augmented Induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R. Transplantation 2005, 79:1180-1183.
116. Gorczynski R., Khatri I., Lee L., Boudakov I. An interaction between CD200 and monoclonal antibody agonists to CD200R2 in development of dendritic cells that preferentially induce populations of CD4+CD25+ T regulatory cells. J. Immunol. 2008, 180:5946-5955.
117. Gorelik L., Flavell R. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000, 12:171-181.
118. Goubier A., Dubois B., Gheit H., Joubert G., Villard-Truc F., Asselin-Paturel C., Trinchieri G., Kaiserlian D. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008, 29:464-475.
119. Grainger J.R., Hall J.A., Bouladoux N., Oldenhove G., Belkaid Y. Microbe-dendritic cell dialog controls regulatory T-cell fate. Immunol. Rev. 2010, 234:305-316.
120. Grainger J.R., Smith K.A., Hewitson J.P., McSorley H.J., Harcus Y., Filbey K.J., Finney C.A.M., Greenwood E.J.D., Knox D.P., Wilson M.S., Belkaid Y., Rudensky A.Y., Maizels R.M. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-{beta} pathway. J. Exp. Med. 2010, PMID: 20876311.
121. Gregori S., Magnani C.F., Roncarolo M.-G. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells. Hum. Immunol. 2009, 70:966-969.
122. Gregori S., Tomasoni D., Pacciani V., Scirpoli M., Battaglia M., Magnani C.F., Hauben E., Roncarolo M.-G. Differentiation of type 1 T regulatory (Tr1) cells by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood. 2010, 116:935-944.
123. Grider J.R., Rivier J.R. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: Evidence from the use of selective VIP antagonists and VIP antiserum. J. Pharmacol. Exp. Ther. 1990, 253:738-742.
124. Griffin M., Lutz W., Phan V., Bachman L., McKean D., Kumar R. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2001, 98:6800-6805.
125. Grohmann U., Volpi C., Fallarino F., Bozza S., Bianchi R., Vacca C., Orabona C., Belladonna M.L., Ayroldi E., Nocentini G., Boon L., Bistoni F., et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat. Med. 2007, 13:579-586.
126. Guilliams M., Crozat K., Henri S., Tamoutounour S., Grenot P., Devilard E., De Bovis B., Alexopoulou L., Dalod M., Malissen B. Skin-draining lymph nodes contain dermis-derived CD103- dendritic cells that constitutively produce retinoic acid and induce Foxp3+ regulatory T cells. Blood 2010, 115:1958-1968.
127. Hackstein H., Thomson A.W. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004, 4:24-34.
128. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., Butcher E.C. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 2008, 9:1253-1260.
129. Hammad H., Chieppa M., Perros F., Willart M.A., Germain R.N., Lambrecht B.N. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 2009, 15:410-416.
130. Harada Y., Harada Y., Elly C., Ying G., Paik J.-H., Depinho R.A., Liu Y.-C. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 2010, 207:1381-1391.
131. Haxhinasto S., Mathis D., Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 2008, 205:565-574.
132. Hay N. Upstream and downstream of mTOR. Genes Dev. 2004, 18:1926-1945.
133. Henry E., Desmet C.J., Garzé V., Fiévez L., Bedoret D., Heirman C., Faisca P., Jaspar F.J., Gosset P., Jacquet A.P.A., Desmecht D., Thielemans K., et al. Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J. Immunol. 2008, 181:7230-7242.
134. Hermann-Kleiter N., Baier G. NFAT pulls the strings during CD4+ T helper cell effector functions. Blood 2010, 115:2989-2997.
135. Hill J.A., Feuerer M., Tash K., Haxhinasto S., Perez J., Melamed R., Mathis D., Benoist C. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007, 27:786-800.
136. Hill J.A., Hall J.A., Sun C.-M., Cai Q., Ghyselinck N., Chambon P., Belkaid Y., Mathis D., Benoist C. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 2008, 29:758-770.
137. Hintzen G., Ohl L., del Rio M.-L., Rodriguez-Barbosa J.-I., Pabst O., Kocks J.R., Krege J., Hardtke S., Förster R. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J. Immunol. 2006, 177:7346-7354.
138. Hogan P.G., Lewis R.S., Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 2010, 28:491-533.
139. Horibe E.K., Sacks J., Unadkat J., Raimondi G., Wang Z., Ikeguchi R., Marsteller D., Ferreira L.M., Thomson A.W., Lee W.P.A., Feili-Hariri M. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl. Immunol. 2008, 18:307-318.
140. Hsu D.H., de Waal Malefyt R., Fiorentino D.F., Dang M.N., Vieira P., de Vries J., Spits H., Mosmann T.R., Moore K.W. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990, 250:830-832.
141. Hu H., Djuretic I., Sundrud M., Rao A. Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT. Trends Immunol. 2007, 28:329-332.
142. Hultkrantz S., Ostman S., Telemo E. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Immunology 2005, 116:362-372.
143. Ikushima H., Miyazono K. TGFbeta signalling: A complex web in cancer progression. Nat. Rev. Cancer 2010, 10:415-424.
144. Ilarregui J.M., Croci D.O., Bianco G.A., Toscano M.A., Salatino M., Vermeulen M.E., Geffner J.R., Rabinovich G.A. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009, 1-13.
145. Iliev I.D., Spadoni I., Mileti E., Matteoli G., Sonzogni A., Sampietro G.M., Foschi D., Caprioli F., Viale G., Rescigno M. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009, 58:1481-1489.
146. Iliev I.D., Mileti E., Matteoli G., Chieppa M., Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol. 2009, 2:340-350.
147. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
148. Iruretagoyena M.I., Sepúlveda S.E., Lezana J.P., Hermoso M., Bronfman M., Gutiérrez M.A., Jacobelli S.H., Kalergis A.M. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J. Pharmacol. Exp. Ther. 2006, 318:59-67.
149. Ito T., Yang M., Wang Y.-H., Lande R., Gregorio J., Perng O.A., Qin X.-F., Liu Y.-J., Gilliet M. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007, 204:105-115.
150. Iwata M. Retinoic acid production by intestinal dendritic cells and its role in T-cell trafficking. Semin. Immunol. 2009, 21:8-13.
151. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., Song S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004, 21:527-538.
152. Jakubzick C., Bogunovic M., Bonito A.J., Kuan E.L., Merad M., Randolph G.J. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J. Exp. Med. 2008, 205:2839-2850.
153. Jang M.H., Sougawa N., Tanaka T., Hirata T., Hiroi T., Tohya K., Guo Z., Umemoto E., Ebisuno Y., Yang B.G., Seoh J.Y., Lipp M., et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 2006, 176:803-810.
154. Jiang A., Bloom O., Ono S., Cui W., Unternaehrer J., Jiang S., Whitney J.A., Connolly J., Banchereau J., Mellman I. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007, 27:610-624.
155. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000, 192:1213-1222.
156. Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., Enk A.H. Infectious tolerance: Human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 2002, 196:255-260.
157. Jurgens B., Hainz U., Fuchs D., Felzmann T., Heitger A. Interferon-gamma triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood. 2009, 114:3235-3243.
158. Karlsson G., Liu Y., Larsson J., Goumans M.-J., Lee J.-S., Thorgeirsson S.S., Ringnér M., Karlsson S. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling. Physiol. Genomics 2005, 21:396-403.
159. Katz J.B., Muller A.J., Prendergast G.C. Indoleamine 2, 3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol. Rev. 2008, 222:206-221.
160. Keir M.E., Francisco L.M., Sharpe A.H. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 2007, 19:309-314.
161. Kelly R.J., Morris J.C. Transforming growth factor-beta: A target for cancer therapy. J. Immunotoxicol. 2010, 7:15-26.
162. Kim J.M., Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol. Rev. 2006, 212:86-98.
163. Kim G.-Y., Cho H., Ahn S.-C., Oh Y.-H., Lee C.-M., Park Y.-M. Resveratrol inhibits phenotypic and functional maturation of murine bone marrow-derived dendritic cells. Int. Immunopharmacol. 2004, 4:245-253.
164. Kim B.-G., Li C., Qiao W., Mamura M., Kasprzak B., Kasperczak B., Anver M., Wolfraim L., Hong S., Mushinski E., Potter M., Kim S.-J., et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 2006, 441:1015-1019.
165. King I.L., Segal B.M. Cutting edge: IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells. J. Immunol. 2005, 175:641-645.
166. Ko H.-J., Cho M.-L., Lee S.-Y., Oh H.-J., Heo Y.-J., Moon Y.-M., Kang C.-M., Kwok S.-K., Ju J.H., Park S.-H., Park K.-S., Kim H.-Y. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population. J. Autoimmun. 2010, 34:111-120.
167. Korom S., Boehler A., Weder W. Immunosuppressive therapy in lung transplantation: State of the art. Eur. J. Cardiothorac. Surg. 2009, 35:1045-1055.
168. Kotenko S.V., Saccani S., Izotova L.S., Mirochnitchenko O.V., Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 2000, 97:1695-1700.
169. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 2005, 6:1219-1227.
170. Kretschmer K., Apostolou I., Jaeckel E., Khazaie K., von Boehmer H. Making regulatory T cells with defined antigen specificity: Role in autoimmunity and cancer. Immunol. Rev. 2006, 212:163-169.
171. Kubsch S., Graulich E., Knop J., Steinbrink K. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: Association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1. Eur. J. Immunol. 2003, 33:1988-1997.
172. Lambrecht B.N., Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009, 31:412-424.
173. Lang R., Patel D., Morris J.J., Rutschman R.L., Murray P.J. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 2002, 169:2253-2263.
174. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000, 1:311-316.
175. Langenkamp A., Casorati G., Garavaglia C., Dellabona P., Lanzavecchia A., Sallusto F. T cell priming by dendritic cells: Thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur. J. Immunol. 2002, 32:2046-2054.
176. Lanteri M.C., O'Brien K.M., Purtha W.E., Cameron M.J., Lund J.M., Owen R.E., Heitman J.W., Custer B., Hirschkorn D.F., Tobler L.H., Kiely N., Prince H.E., et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J. Clin. Invest. 2009, 119:3266-3277.
177. Laouar Y., Sutterwala F.S., Gorelik L., Flavell R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 2005, 6:600-607.
178. Laouar Y., Town T., Jeng D., Tran E., Wan Y., Kuchroo V.K., Flavell R.A. TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2008, 105:10865-10870.
179. Laplante M., Sabatini D.M. mTOR signaling at a glance. J. Cell Sci. 2009, 122:3589-3594.
180. Lau A.W.T., Biester S., Cornall R.J., Forrester J.V. Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J. Immunol. 2008, 180:3889-3899.
181. Lavelle E., McNeela E., Armstrong M., Leavy O., Higgins S., Mills K. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 2003, 171:2384-2392.
182. Leung D.Y.M., Bloom J.W. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 2003, 111:3-22. (quiz 23).
183. Levings M., Gregori S., Tresoldi E., Cazzaniga S., Bonini C., Roncarolo M. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005, 105:1162-1169.
184. Li Q., Guo Z., Xu X., Xia S., Cao X. Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflammation. Eur. J. Immunol. 2008, 38:2751-2761.
185. Li X., Yang A., Huang H., Zhang X., Town J., Davis B., Cockcroft D.W., Gordon J.R. Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells. Am. J. Respir. Cell Mol. Biol. 2010, 42:190-199.
186. Liang S., Ristich V., Arase H., Dausset J., Carosella E.D., Horuzsko A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc. Natl. Acad. Sci. USA 2008, 105:8357-8362.
187. Lio C.-W.J., Hsieh C.-S. A two-step process for thymic regulatory T cell development. Immunity 2008, 28:100-111.
188. Lipscomb M.W., Taylor J.L., Goldbach C.J., Watkins S.C., Wesa A.K., Storkus W.J. DC expressing transgene Foxp3 are regulatory APC. Eur. J. Immunol. 2010, 40:480-493.
189. Liston A., Nutsch K.M., Farr A.G., Lund J.M., Rasmussen J.P., Koni P.A., Rudensky A.Y. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc. Natl. Acad. Sci. USA 2008, 105:11903-11908.
190. Liu K., Nussenzweig M.C. Origin and development of dendritic cells. Immunol. Rev. 2010, 234:45-54.
191. Liu Y., Bi X., Xu S., Xiang J. Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses. Cancer Res. 2005, 65:4955-4962.
192. Liu Y.-J., Soumelis V., Watanabe N., Ito T., Wang Y.-H., Malefyt R.D.W., Omori M., Zhou B., Ziegler S.F. TSLP: An epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol. 2007, 25:193-219.
193. Liu T., Chen X., Feng B.-S., He S.-H., Zhang T.-Y., Wang B.-Q., Yang P.-C. Glucuronoxylomannan promotes the generation of antigen-specific T regulatory cell that suppresses the antigen specific Th2 response upon activation. J. Cell. Mol. Med. 2008, 13:1765-1774.
194. Liu K., Victora G., Schwickert T., Guermonprez P., Meredith M., Yao K., Chu F., Randolph G., Rudensky A., Nussenzweig M. In vivo analysis of dendritic cell development and homeostasis. Science. 2009, 324:392-397.
195. Lloyd C.M., Hawrylowicz C.M. Regulatory T cells in asthma. Immunity 2009, 31:438-449.
196. Löb S., Königsrainer A. Role of IDO in organ transplantation: Promises and difficulties. Int. Rev. Immunol. 2009, 28:185-206.
197. Lund J., Hsing L., Pham T., Rudensky A. Coordination of early protective immunity to viral infection by regulatory T cells. Science. 2008, 320:1220-1224.
198. Lüth S., Huber S., Schramm C., Buch T., Zander S., Stadelmann C., Brück W., Wraith D.C., Herkel J., Lohse A.W. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J. Clin. Invest. 2008, 118:3403-3410.
199. Luther C., Adamopoulou E., Stoeckle C., Brucklacher-Waldert V., Rosenkranz D., Stoltze L., Lauer S., Poeschel S., Melms A., Tolosa E. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J. Immunol. 2009, 183:841-848.
200. Mahnke K., Qian Y., Knop J., Enk A.H. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003, 101:4862-4869.
201. Manavalan J.S., Rossi P.C., Vlad G., Piazza F., Yarilina A., Cortesini R., Mancini D., Suciu-Foca N. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 2003, 11:245-258.
202. Manicassamy S., Pulendran B. Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages. Semin. Immunol. 2009, 21:22-27.
203. Martin E., O'Sullivan B., Low P., Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 2003, 18:155-167.
204. Martin P., Del Hoyo G.M., Anjuere C., Arias C.F., Vargas H.H., Fernandez L.A., Parrillas V., Ardavin C. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002, 100:383-390.
205. Martin-Fontecha A., Sebastiani S., Hopken U.E., Uguccioni M., Lipp M., Lanzavecchia A., Sallusto F. Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J. Exp. Med. 2003, 198:615-621.
206. Martín-Gayo E., Sierra-Filardi E., Corbí A.L., Toribio M.L. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood. 2010, 115(26):5366-5375.
207. Martino A.T., Nayak S., Hoffman B.E., Cooper M., Liao G., Markusic D.M., Byrne B.J., Terhorst C., Herzog R.W. Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: Implications for antigen presentation and immunotoxicity. PLoS ONE 2009, 4:e6376.
208. Mascarell L., Lombardi V., Louise A., Saint-Lu N., Chabre H., Moussu H., Betbeder D., Balazuc A.-M., Van Overtvelt L., Moingeon P. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. J. Allergy Clin. Immunol. 2008, 122:603-609.e605.
209. Massey D.C.O., Bredin F., Parkes M. Use of sirolimus (rapamycin) to treat refractory Crohn's disease. Gut 2008, 57:1294-1296.
210. Matsumura Y., Kobayashi T., Ichiyama K., Yoshida R., Hashimoto M., Takimoto T., Tanaka K., Chinen T., Shichita T., Wyss-Coray T., Sato K., Yoshimura A. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J. Immunol. 2007, 179:2170-2179.
211. Matteoli G., Mazzini E., Iliev I.D., Mileti E., Fallarino F., Puccetti P., Chieppa M., Rescigno M. Gut CD103+ dendritic cells express indoleamine 2, 3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010, 59:595-604.
212. Mazzucchelli R., Hixon J., Spolski R., Chen X., Li W., Hall V., Willette-Brown J., Hurwitz A., Leonard W., Durum S. Development of regulatory T cells requires IL-7R{alpha} stimulation by IL-7 or TSLP. Blood. 2008, 112:3283-3292.
213. McGuirk P., McCann C., Mills K.H.G. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 2002, 195:221-231.
214. McIlroy D., Tanguy-Royer S., Le Meur N., Guisle I., Royer P.-J., Léger J., Meflah K., Grégoire M. Profiling dendritic cell maturation with dedicated microarrays. J. Leukoc. Biol. 2005, 78:794-803.
215. Mekala D.J., Alli R.S., Geiger T.L. IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc. Natl. Acad. Sci. USA 2005, 102:11817-11822.
216. Mellor A.L., Munn D.H. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat. Rev. Immunol. 2004, 4:762-774.
217. Menges M., Rössner S., Voigtländer C., Schindler H., Kukutsch N.A., Bogdan C., Erb K., Schuler G., Lutz M.B. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 2002, 195:15-21.
218. Meylan E., Tschopp J. Toll-like receptors and RNA helicases: Two parallel ways to trigger antiviral responses. Mol. Cell 2006, 22:561-569.
219. Milling S., Yrlid U., Cerovic V., MacPherson G. Subsets of migrating intestinal dendritic cells. Immunol. Rev. 2010, 234:259-267.
220. Mills K.H.G., McGuirk P. Antigen-specific regulatory T cells-Their induction and role in infection. Semin. Immunol. 2004, 16:107-117.
221. Min W.-P., Zhou D., Ichim T.E., Strejan G.H., Xia X., Yang J., Huang X., Garcia B., White D., Dutartre P., Jevnikar A.M., Zhong R. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J. Immunol. 2003, 170:1304-1312.
222. Min S.-Y., Park K.-S., Cho M.-L., Kang J.-W., Cho Y.-G., Hwang S.-Y., Park M.-J., Yoon C.-H., Min J.-K., Lee S.-H., Park S.-H., Kim H.-Y. Antigen-induced, tolerogenic CD11c+, CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. Arthritis Rheum. 2006, 54:887-898.
223. Min B., Thornton A., Caucheteux S.M., Younes S.-A., Oh K., Hu-Li J., Paul W.E. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur. J. Immunol. 2007, 37:1916-1923.
224. Miyamoto K., Kingsley C.I., Zhang X., Jabs C., Izikson L., Sobel R.A., Weiner H.L., Kuchroo V.K., Sharpe A.H. The ICOS molecule plays a crucial role in the development of mucosal tolerance. J. Immunol. 2005, 175:7341-7347.
225. Miyazono K. Positive and negative regulation of TGF-beta signaling. J. Cell Sci. 2000, 113(Pt. 7):1101-1109.
226. Mold J.E., Michaelsson J., Burt T.D., Muench M.O., Beckerman K.P., Busch M.P., Lee T.-H., Nixon D.F., Mccune J.M. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008, 322:1562-1565.
227. Monti P., Leone B.E., Zerbi A., Balzano G., Cainarca S., Sordi V., Pontillo M., Mercalli A., Di Carlo V., Allavena P., Piemonti L. Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell. J. Immunol. 2004, 172:7341-7349.
228. Monti P., Scirpoli M., Maffi P., Piemonti L., Secchi A., Bonifacio E., Roncarolo M.-G., Battaglia M. Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells. Diabetes 2008, 57:2341-2347.
229. Moore K., de Waal Malefyt R., Coffman R., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
230. Mora J.R., Iwata M., Eksteen B., Song S.Y., Junt T., Senman B., Otipoby K.L., Yokota A., Takeuchi H., Ricciardi-Castagnoli P., Rajewsky K., Adams D.H., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314:1157-1160.
231. Mora J., Iwata M., Von Andrian U. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat. Rev. Immunol. 2008, 8:685-698.
232. Morelli A.E., Thomson A.W. Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 2003, 196:125-146.
233. Morelli A., Thomson A. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007, 7:610-621.
234. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.-J., Blazar B.R., Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 2004, 173:4433-4442.
235. Mucida D., Pino-Lagos K., Kim G., Nowak E., Benson M.J., Kronenberg M., Noelle R.J., Cheroutre H. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 2009, 30:471-472. (author reply 472-473).
236. Murai M., Turovskaya O., Kim G., Madan R., Karp C.L., Cheroutre H., Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 2009, 10:1178-1184.
237. Murray P.J. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 2005, 102:8686-8691.
238. Murray P.J. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 2006, 6:379-386.
239. Nilsen E.M., Johansen F.E., Jahnsen F.L., Lundin K.E., Scholz T., Brandtzaeg P., Haraldsen G. Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 1998, 42:635-642.
240. Nolting J., Daniel C., Reuter S., Stuelten C., Li P., Sucov H., Kim B., Letterio J., Kretschmer K., Kim H., von Boehmer H. Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J. Exp. Med. 2009, 206:2131-2139.
241. Ochando J.C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., Angeli V., Li Y., Boros P., Ding Y., Jessberger R., Trinchieri G., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 2006, 7:652-662.
242. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., Blankenstein T., Henning G., Forster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity. 2004, 21:279-288.
243. Ohnmacht C., Pullner A., King S.B.S., Drexler I., Meier S., Brocker T., Voehringer D. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 2009, 206:549-559.
244. Ohtani M., Nagai S., Kondo S., Mizuno S., Nakamura K., Tanabe M., Takeuchi T., Matsuda S., Koyasu S. mTOR and GSK3 differentially regulate LPS-induced IL-12 production in dendritic cells. Blood. 2008, 112:635-643.
245. Orabona C., Puccetti P., Vacca C., Bicciato S., Luchini A., Fallarino F., Bianchi R., Velardi E., Perruccio K., Velardi A., Bronte V., Fioretti M.C., et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 2006, 107:2846-2854.
246. Ostroukhova M., Seguin-Devaux C., Oriss T.B., Dixon-McCarthy B., Yang L., Ameredes B.T., Corcoran T.E., Ray A. Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J. Clin. Invest. 2004, 114:28-38.
247. Pacciani V., Gregori S., Chini L., Corrente S., Chianca M., Moschese V., Rossi P., Roncarolo M.G., Angelini F. Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites. J. Allergy Clin. Immunol. 2010, 125:727-736.
248. Pandiyan P., Zheng L., Ishihara S., Reed J., Lenardo M.J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 2007, 8:1353-1362.
249. Park M.-J., Min S.-Y., Park K.-S., Cho Y.-G., Cho M.-L., Jung Y.-O., Park H.-S., Chang S.-H., Cho S.G., Min J.-K., Park S.-H., Kim H.-Y. Indoleamine 2, 3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model. Arthritis Res. Ther. 2008, 10:R11.
250. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
251. Paust S., Cantor H. Regulatory T cells and autoimmune disease. Immunol. Rev. 2005, 204:195-207.
252. Pearce E.L. Metabolism in T cell activation and differentiation. Curr. Opin. Immunol. 2010, 22:314-320.
253. Pearce E.L., Walsh M.C., Cejas P.J., Harms G.M., Shen H., Wang L.-S., Jones R.G., Choi Y. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009, 460:103-107.
254. Penna G., Giarratana N., Amuchastegui S., Mariani R., Daniel K.C., Adorini L. Manipulating dendritic cells to induce regulatory T cells. Microbes Infect. 2005, 7:1033-1039.
255. Penna G., Roncari A., Amuchastegui S., Daniel K.C., Berti E., Colonna M., Adorini L. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1, 25-dihydroxyvitamin D3. Blood 2005, 106:3490-3497.
256. Penna G., Amuchastegui S., Laverny G., Adorini L. Vitamin D receptor agonists in the treatment of autoimmune diseases: Selective targeting of myeloid but not plasmacytoid dendritic cells. J. Bone Miner. Res. 2007, 22(Suppl. 2):V69-V73.
257. Perrier P., Martinez F.O., Locati M., Bianchi G., Nebuloni M., Vago G., Bazzoni F., Sozzani S., Allavena P., Mantovani A. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: Induction of the B cell-activating chemokine, CXC chemokine ligand 13. J. Immunol. 2004, 172:7031-7042.
258. Pervaiz S., Holme A.L. Resveratrol: Its biologic targets and functional activity. Antioxid. Redox Signal. 2009, 11:2851-2897.
259. Pétrilli V., Dostert C., Muruve D.A., Tschopp J. The inflammasome: A danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 2007, 19:615-622.
260. Pettersson A., Ciumas C., Chirsky V., Link H., Huang Y.-M., Xiao B.-G. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis. J. Neuroimmunol. 2004, 156:58-65.
261. Picca C.C., Larkin J., Boesteanu A., Lerman M.A., Rankin A.L., Caton A.J. Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol. Rev. 2006, 212:74-85.
262. Proietto A.I., van Dommelen S., Zhou P., Rizzitelli A., D'Amico A., Steptoe R.J., Naik S.H., Lahoud M.H., Liu Y., Zheng P., Shortman K., Wu L. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc. Natl. Acad. Sci. USA 2008, 105:19869-19874.
263. Proietto A.I., van Dommelen S., Wu L. The impact of circulating dendritic cells on the development and differentiation of thymocytes. Immunol. Cell Biol. 2009, 87:39-45.
264. Puccetti P., Grohmann U. IDO and regulatory T cells: A role for reverse signalling and non-canonical NF-kappaB activation. Nat. Rev. Immunol. 2007, 7:817-823.
265. Pulendran B., Tang H., Denning T. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol. 2008, 20:61-67.
266. Qin H., Vlad G., Cortesini R., Suciu-Foca N., Manavalan J.S. CD8+ suppressor and cytotoxic T cells recognize the same human leukocyte antigen-A2 restricted cytomegalovirus peptide. Hum. Immunol. 2008, 69:776-780.
267. Raimondi G., Sumpter T.L., Matta B.M., Pillai M., Corbitt N., Vodovotz Y., Wang Z., Thomson A.W. Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J. Immunol. 2010, 184:624-636.
268. Re F., Strominger J.L. Heterogeneity of TLR-induced responses in dendritic cells: From innate to adaptive immunity. Immunobiology 2004, 209:191-198.
269. Reis E., Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 2006, 6:476-483.
270. Rémy S., Blancou P., Tesson L., Tardif V., Brion R., Royer P.J., Motterlini R., Foresti R., Painchaut M., Pogu S., Gregoire M., Bach J.M., et al. Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J. Immunol. 2009, 182:1877-1884.
271. Ribot J., Romagnoli P., van Meerwijk J.P.M. Agonist ligands expressed by thymic epithelium enhance positive selection of regulatory T lymphocytes from precursors with a normally diverse TCR repertoire. J. Immunol. 2006, 177:1101-1107.
272. Riley J.L. PD-1 signaling in primary T cells. Immunol. Rev. 2009, 229:114-125.
273. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G.M., Nespoli A., Viale G., Allavena P., Rescigno M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 2005, 6:507-514.
274. Ristich V., Liang S., Zhang W., Wu J., Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur. J. Immunol. 2005, 35:1133-1142.
275. Robinson P.W., Green S.J., Carter C., Coadwell J., Kilshaw P.J. Studies on transcriptional regulation of the mucosal T-cell integrin alphaEbeta7 (CD103). Immunology 2001, 103:146-154.
276. Roca L., Di Paolo S., Petruzzelli V., Grandaliano G., Ranieri E., Schena F.P., Gesualdo L. Dexamethasone modulates interleukin-12 production by inducing monocyte chemoattractant protein-1 in human dendritic cells. Immunol. Cell Biol. 2007, 85:610-616.
277. Romani L., Bistoni F., Perruccio K., Montagnoli C., Gaziano R., Bozza S., Bonifazi P., Bistoni G., Rasi G., Velardi A., Fallarino F., Garaci E., et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 2006, 108:2265-2274.
278. Roncarolo M., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 2007, 7:585-598.
279. Rubtsov Y.P., Rudensky A.Y. TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 2007, 7:443-453.
280. Rutella S., Bonanno G., Procoli A., Mariotti A., De Ritis D.G., Curti A., Danese S., Pessina G., Pandolfi S., Natoni F., Di Febo A., Scambia G., et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006, 108:218-227.
281. Sadlon T.J., Wilkinson B.G., Pederson S., Brown C.Y., Bresatz S., Gargett T., Melville E.L., Peng K., D'Andrea R.J., Glonek G.G., Goodall G.J., Zola H., et al. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J. Immunol. 2010, 185:1071-1081.
282. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
283. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by GM-CSF plus IL-4 and downregulated by TNF-α. J. Exp. Med. 1994, 179:1109-1118.
284. Salter R.D., Watkins S.C. Dendritic cell altered states: What role for calcium?. Immunol. Rev. 2009, 231:278-288.
285. Sargent J.L., Milano A., Bhattacharyya S., Varga J., Connolly M.K., Chang H.Y., Whitfield M.L. A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity. J. Invest. Dermatol. 2010, 130:694-705.
286. Sato K., Yamashita N., Baba M., Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003, 101:3581-3589.
287. Sato K., Yamashita N., Yamashita N., Baba M., Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 2003, 18:367-379.
288. Sato K., Eizumi K., Fukaya T., Fujita S., Sato Y., Takagi H., Yamamoto M., Yamashita N., Hijikata A., Kitamura H., Ohara O., Yamasaki S., et al. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. Blood 2009, 113:4780-4789.
289. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., Knight Z.A., Cobb B.S., Cantrell D., O'Connor E., Shokat K.M., Fisher A.G., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 2008, 105:7797-7802.
290. Schildberg F.A., Hegenbarth S.I., Schumak B., Scholz K., Limmer A., Knolle P.A. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur. J. Immunol. 2008, 38:957-967.
291. Schmitz F., Heit A., Dreher S., Eisenächer K., Mages J., Haas T., Krug A., Janssen K.-P., Kirschning C.J., Wagner H. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol. 2008, 38:2981-2992.
292. Scott-Browne J.P., Shafiani S., Tucker-Heard G., Ishida-Tsubota K., Fontenot J.D., Rudensky A., Bevan M.J., Urdahl K.B. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 2007, 204:2159-2169.
293. Shafiani S., Tucker-Heard G.S., Kariyone A., Takatsu K., Urdahl K.B. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 2010, 207:1409-1420.
294. Shale M., Ghosh S. How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease. Gut 2009, 58:1291-1299.
295. Sharma P.K., Saha P.K., Singh A., Sharma S.K., Ghosh B., Mitra D.K. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am. J. Respir. Crit. Care Med. 2009, 179:1061-1070.
296. Shortman K., Heath W.R. The CD8+ dendritic cell subset. Immunol. Rev. 2010, 234:18-31.
297. Siddiqui K.R.R., Powrie F. CD103+ GALT DCs promote Foxp3+ regulatory T cells. Mucosal Immunol. 2008, 1(Suppl. 1):S34-S38.
298. Sims J.E., Smith D.E. The IL-1 family: Regulators of immunity. Nat. Rev. Immunol. 2010, 10:89-102.
299. Smith T.R.F., Maricic I., Ria F., Schneider S., Kumar V. CD8á+ dendritic cells prime TCR-peptide-reactive regulatory CD4+FOXP3- T cells. Eur. J. Immunol. 2010, 40:1906-1915.
300. Steinbrink K., Graulich E., Kubsch S., Knop J., Enk A.H. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002, 99:2468-2476.
301. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 1973, 137:1142-1162.
302. Steinman R.M., Idoyaga J. Features of the dendritic cell lineage. Immunol. Rev. 2010, 234:5-17.
303. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003, 21:685-711.
304. Stepkowski S.M., Phan T., Zhang H., Bilinski S., Kloc M., Qi Y., Katz S.M., Rutzky L.P. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition. Transplantation 2006, 82:1756-1763.
305. Sun C., Hall J., Blank R., Bouladoux N., Oukka M., Mora J., Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
306. Sundrud M.S., Koralov S.B., Feuerer M., Calado D.P., Kozhaya A.E., Rhule-Smith A., Lefebvre R.E., Unutmaz D., Mazitschek R., Waldner H., Whitman M., Keller T., et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science 2009, 324:1334-1338.
307. Svajger U., Obermajer N., Jeras M. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology 2010, 129:525-535.
308. Swiecki M., Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 2010, 234:142-162.
309. Széles L., Keresztes G., Töröcsik D., Balajthy Z., Krenács L., Póliska S., Steinmeyer A., Zuegel U., Pruenster M., Rot A., Nagy L. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J. Immunol. 2009, 182:2074-2083.
310. Takaki H., Ichiyama K., Koga K., Chinen T., Takaesu G., Sugiyama Y., Kato S., Yoshimura A., Kobayashi T. STAT6 inhibits TGF-beta 1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J. Biol. Chem. 2008, 283:14955-14962.
311. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat. Immunol. 2008, 9:239-244.
312. Taylor A., Akdis M., Joss A., Akkoç T., Wenig R., Colonna M., Daigle I., Flory E., Blaser K., Akdis C.A. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J. Allergy Clin. Immunol. 2007, 120:76-83.
313. Taylor B.C., Zaph C., Troy A.E., Du Y., Guild K.J., Comeau M.R., Artis D. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J. Exp. Med. 2009, 206:655-667.
314. Taylor A., Verhagen J., Akkoç T., Wenig R., Flory E., Blaser K., Akdis M., Akdis C.A. IL-10 suppresses CD2-mediated T cell activation via SHP-1. Mol. Immunol. 2009, 46:622-629.
315. Thomson A.W., Turnquist H.R., Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 2009, 9:324-337.
316. Tiegs G., Lohse A.W. Immune tolerance: What is unique about the liver. J. Autoimmun. 2010, 34:1-6.
317. Tisch R. Immunogenic versus tolerogenic dendritic cells: A matter of maturation. Int. Rev. Immunol. 2010, 29:111-118.
318. Tomasoni S., Aiello S., Cassis L., Noris M., Longaretti L., Cavinato R.A., Azzollini N., Pezzotta A., Remuzzi G., Benigni A. Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells. Transplantation 2005, 79:1056-1061.
319. Torres-Aguilar H., Aguilar-Ruiz S.R., González-Pérez G., Munguía R., Bajaña S., Meraz-Ríos M.A., Sánchez-Torres C. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J. Immunol. (Baltimore, MD: 1950) 2010, 184:1765-1775.
320. Travis M.A., Reizis B., Melton A.C., Masteller E., Tang Q., Proctor J.M., Wang Y., Bernstein X., Huang X., Reichardt L.F., Bluestone J.A., Sheppard D. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007, 449:361-365.
321. Tsuji N.M., Kosaka A. Oral tolerance: Intestinal homeostasis and antigen-specific regulatory T cells. Trends Immunol. 2008, 29:532-540.
322. Tuettenberg A., Huter E., Hubo M., Horn J., Knop J., Grimbacher B., Kroczek R.A., Stoll S., Jonuleit H. The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells. J. Immunol. 2009, 182:3349-3356.
323. Türeci O., Bian H., Nestle F.O., Raddrizzani L., Rosinski J.A., Tassis A., Hilton H., Walstead M., Sahin U., Hammer J. Cascades of transcriptional induction during dendritic cell maturation revealed by genome-wide expression analysis. FASEB J. 2003, 17:836-847.
324. Turnquist H.R., Raimondi G., Zahorchak A.F., Fischer R.T., Wang Z., Thomson A. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J. Immunol. 2007, 178:7018-7031.
325. Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., Di Pucchio T., Connolly J., Fay J.W., Pascual V., Palucka A.K., Banchereau J. Dendritic cell subsets in health and disease. Immunol. Rev. 2007, 219:118-142.
326. Unger W.W.J., Laban S., Kleijwegt F.S., van der Slik A.R., Roep B.O. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1. Eur. J. Immunol. 2009, 39:3147-3159.
327. Ureta G., Osorio F., Morales J., Rosemblatt M., Bono M.R., Fierro J.A. Generation of dendritic cells with regulatory properties. Transplant. Proc. 2007, 39:633-637.
328. Urzainqui A., Martínez del Hoyo G., Lamana A., de la Fuente H., Barreiro O., Olazabal I.M., Martin P., Wild M.K., Vestweber D., González-Amaro R., Sánchez-Madrid F. Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J. Immunol. 2007, 179:7457-7465.
329. Valle A., Jofra T., Stabilini A., Atkinson M., Roncarolo M.-G., Battaglia M. Rapamycin prevents and breaks the anti-CD3-induced tolerance in NOD mice. Diabetes 2009, 58:875-881.
330. Veillette A., Latour S. The SLAM family of immune-cell receptors. Curr. Opin. Immunol. 2003, 15:277-285.
331. Verginis P., Li H.S., Carayanniotis G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J. Immunol. 2005, 174:7433-7439.
332. Vermaelen K.Y., Carro-Muino I., Lambrecht B.N., Pauwels R.A. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 2001, 193:51-60.
333. Vignali D., Collison L., Workman C. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
334. Vigouroux S., Yvon E., Biagi E., Brenner M.K. Antigen-induced regulatory T cells. Blood 2004, 104:26-33.
335. Vlad G., Chang C.-C., Colovai A.I., Berloco P., Cortesini R., Suciu-Foca N. Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function. Hum. Immunol. 2009, 70:340-344.
336. Vlad G., Chang C.-C., Colovai A.I., Vasilescu E.R., Cortesini R., Suciu-Foca N. Membrane and soluble ILT3 are critical to the generation of T suppressor cells and induction of immunological tolerance. Int. Rev. Immunol. 2010, 29:119-132.
337. von Boehmer H. Oral tolerance: Is it all retinoic acid?. J. Exp. Med. 2007, 204:1737-1739.
338. Vremec D., Zorbas M., Scollay R., Saunders D.J., Ardavin C.F., Wu L., Shortman K. The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 1992, 176:47-58.
339. Wakkach A., Fournier N., Brun V., Breittmayer J., Cottrez F., Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003, 18:605-617.
340. Waldmann H., Adams E., Fairchild P., Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 2006, 212:301-313.
341. Wang J., Xing F. Human TSLP-educated DCs. Cell. Mol. Immunol. 2008, 5:99-106.
342. Wang L., Pino-Lagos K., de Vries V., Guleria I., Sayegh M., Noelle R. Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 2008, 105:9331-9336.
343. Wang X., Zhou S., Chi Y., Wen X., Hoellwarth J., He L., Liu F., Wu C., Dhesi S., Zhao J., Hu W., Su C. CD4+CD25+ Treg induction by an HSP60-derived peptide SJMHE1 from Schistosoma japonicum is TLR2 dependent. Eur. J. Immunol. 2009, 39:3052-3065.
344. Watanabe N., Wang Y.-H., Lee H.K., Ito T., Wang Y.-H., Cao W., Liu Y.-J. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005, 436:1181-1185.
345. Wei S., Kryczek I., Zou L., Daniel B., Cheng P., Mottram P., Curiel T., Lange A., Zou W. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res. 2005, 65:5020-5026.
346. Worbs T., Bode U., Yan S., Hoffmann M.W., Hintzen G., Bernhardt G., Förster R., Pabst O. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 2006, 203:519-527.
347. Wu J., Horuzsko A. Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells. Hum. Immunol. 2009, 70:353-356.
348. Xia S., Guo Z., Xu X., Yi H., Wang Q., Cao X. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells maintaining liver tolerance. Blood. 2008, 112:3175-3185.
349. Yamashita K., Ollinger R., McDaid J., Sakahama H., Wang H., Tyagi S., Csizmadia E., Smith N.R., Soares M.P., Bach F.H. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J. 2006, 20:776-778.
350. Yamaura A., Hotta C., Nakazawa M., Van Kaer L., Minami M. Human invariant Valpha24+ natural killer T cells acquire regulatory functions by interacting with IL-10-treated dendritic cells. Blood 2008, 111:4254-4263.
351. Yamazaki S., Dudziak D., Heidkamp G.F., Fiorese C., Bonito A.J., Inaba K., Nussenzweig M.C., Steinman R.M. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 2008, 181:6923-6933.
352. Yang H., Zhang Y., Wu M., Li J., Zhou W., Li G., Li X., Xiao B., Christadoss P. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile. Inflamm. Res. 2010, 59:197-205.
353. Yigit R., Massuger L.F.A.G., Figdor C.G., Torensma R. Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol. Oncol. 2010, 117:366-372.
354. Zang W., Lin M., Kalache S., Zhang N., Krüger B., Waaga-Gasser A.M., Grimm M., Hancock W., Heeger P., Schröppel B., Murphy B. Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide. J. Immunol. 2008, 181:7499-7506.
355. Zhang X., Izikson L., Liu L., Weiner H.L. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J. Immunol. 2001, 167:4245-4253.
356. Zhang X., Huang H., Yuan J., Sun D., Hou W.-S., Gordon J., Xiang J. CD4-8- dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity. J. Immunol. 2005, 175:2931-2937.
357. Zhang X., Li M., Lian D., Zheng X., Zhang Z.-X., Ichim T.E., Xia X., Huang X., Vladau C., Suzuki M., Garcia B., Jevnikar A.M., et al. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin. Immunol. 2008, 127:313-321.
358. Zhang Y., Yang H., Xiao B., Wu M., Zhou W., Li J., Li G., Christadoss P. Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis. Mol. Immunol. 2009, 46:657-667.
359. Zhang N., Schröppel B., Lal G., Jakubzick C., Mao X., Chen D., Yin N., Jessberger R., Ochando J.C., Ding Y., Bromberg J.S. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 2009, 30:458-469.
360. Zheng X., Suzuki M., Ichim T.E., Zhang X., Sun H., Zhu F., Shunnar A., Garcia B., Inman R.D., Min W. Treatment of autoimmune arthritis using rna interference-modulated dendritic cells. J. Immunol. (Baltimore, Md: 1950). 2010, 184:6457-6464.
361. Ziegler S.F., Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 2010, 11:289-293.
362. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006, 6:295-307.
363. Zozulya A.L., Ortler S., Lee J., Weidenfeller C., Sandor M., Wiendl H., Fabry Z. Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS. J. Neurosci. 2009, 29:140-152.